Accrual and retention of diverse patients in psychosocial cancer clinical trials

被引:2
|
作者
Hanvey, Grace Ann [1 ]
Padron, Adaixa [1 ]
Kacel, Elizabeth L. [1 ]
Cartagena, Gabriel [1 ]
Bacharz, Kelsey C. [1 ]
McCrae, Christina S. [1 ]
Robinson, Michael E. [1 ]
Waxenberg, Lori B. [1 ]
Antoni, Michael H. [2 ]
Berry, Richard B. [3 ]
Schultz, Gregory S. [4 ]
Castagno, Jacqueline [4 ]
Pereira, Deidre B. [1 ]
机构
[1] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA
[2] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA
[3] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA
[4] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
Cancer; clinical trials; recruitment; retention; health disparities; SLEEP QUALITY INDEX; PSYCHOMETRIC PROPERTIES; PARTICIPATION; POPULATIONS; MINORITIES; INVENTORY; BARRIERS; HEALTH; PAIN;
D O I
10.1017/cts.2022.380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to examine sociodemographic inequities in CCT interest, eligibility, enrollment, decline motivation, and attrition across two psychosocial CCTs for gynecologic, gastrointestinal, and thoracic cancers. Methods: Patients were approached for recruitment to one of two interventions: (1) a randomized control trial (RCT) examining effects of a cognitive-behavioral intervention targeting sleep, pain, mood, cytokines, and cortisol following surgery, or (2) a yoga intervention to determine its feasibility, acceptability, and effects on mitigating distress. Prospective RCT participants were queried about interest and screened for eligibility. All eligible patients across trials were offered enrollment. Patients who declined yoga intervention enrollment provided reasons for decline. Sociodemographic predictors of enrollment decisions and attrition were explored. Results: No sociodemographic differences in RCT interest were observed, and older patients were more likely to be ineligible. Eligible Hispanic patients across trials were significantly more likely to enroll than non-Hispanic patients. Sociodemographic factors predicted differences in decline motivation. In one trial, individuals originating from more urban areas were more likely to prematurely discontinue participation. Discussion: These results corroborate evidence of no significant differences in CCT interest across minority groups, with older adults less likely to fulfill eligibility criteria. While absolute Hispanic enrollment was modest, Hispanic patients were more likely to enroll relative to non-Hispanic patients. Additional sociodemographic trends were noted in decline motivation and geographical prediction of attrition. Further investigation is necessary to better understand inequities, barriers, and best recruitment practices for representative CCTs.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Increasing accrual of minority patients in breast cancer clinical trials
    Trant, Amelia A.
    Walz, Lucas
    Allen, Whitney
    DeJesus, Jose
    Hatzis, Christos
    Silber, Andrea
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (02) : 499 - 505
  • [2] Increasing accrual of minority patients in breast cancer clinical trials
    Amelia A. Trant
    Lucas Walz
    Whitney Allen
    Jose DeJesus
    Christos Hatzis
    Andrea Silber
    [J]. Breast Cancer Research and Treatment, 2020, 184 : 499 - 505
  • [3] Strengthening accrual to cancer clinical trials
    Trimble, Edward L.
    Denicoff, Andrea M.
    Abrams, Jeffrey S.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 291 - 292
  • [4] Accrual and retention trends among diverse patients in a supportive cancer care trial.
    Hanvey, Grace A.
    Padron, Adaixa
    Kacel, Elizabeth L.
    Ulfig, Chantel
    Pereira, Deidre B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [5] Conceptual Model for Accrual to Cancer Clinical Trials
    Lee, Simon J. Craddock
    Murphy, Caitlin C.
    Geiger, Ann M.
    Gerber, David E.
    Cox, John V.
    Nair, Rasmi
    Skinner, Celette Sugg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (23) : 1993 - +
  • [6] Accrual issues in genitourinary cancer clinical trials
    Lara, Primo N., Jr.
    White, Ralph de Vere
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 379 - 383
  • [7] ACCRUAL OF RADIOTHERAPY PATIENTS TO CLINICAL-TRIALS
    LEE, JY
    BREAUX, SR
    [J]. CANCER, 1983, 52 (06) : 1014 - 1016
  • [8] Pancreatic Cancer Clinical Trials and Accrual in the United States
    Hoos, William A.
    James, Porsha M.
    Rahib, Lola
    Talley, Anitra W.
    Fleshman, Julie M.
    Matrisian, Lynn M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) : 3432 - +
  • [9] Accrual to clinical trials at selected comprehensive cancer centers
    Dilts, D. M.
    Sandler, A. B.
    Cheng, S.
    Crites, J.
    Ferranti, L.
    Wu, A.
    Bookman, M. A.
    Thomas, J. P.
    Ostroff, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Increasing Clinical Trials Accrual at a Comprehensive Cancer Center
    Powell, Bayard L.
    Olson, Debbie
    Morrell, Robert M.
    Hales, Terry L.
    High, Kevin P.
    Abraham, Edward
    [J]. BLOOD, 2014, 124 (21)